lobbying_activities: 1954492

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1954492	36235c2e-6b77-425e-8624-9ab1abeaf601	Q1	RED+BLUE STRATEGIES	400693064	COHERUS BIOSCIENCES	2017	first_quarter	PHA	S. 771 - A bill to improve access to affordable prescription drugs - issues related to ensuring a healthy market for biosimilar medications. Issues related to the upcoming biosimilars User Fee Agreement legislation. Issues related to the treatment of biosimilar medications in Medicare Part B and D programs. Issues related to the maintenance of current IPR laws.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2017-04-17T15:01:23.567000-04:00